IBS

Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company’s Scientific Advisory Board

Retrieved on: 
Tuesday, January 10, 2023
Gastroesophageal reflux disease, Constipation, United States Air Force Scientific Advisory Board, Indigestion, The American Journal of Gastroenterology, Gastroparesis, Intestinal pseudo-obstruction, Lacy, Rome, Stomach, Mayo Clinic, IBS, Visceral pain, Gastrointestinal tract, Textbook, Patient, Diet, Research, Irritable bowel syndrome, Clinical and Translational Gastroenterology, Science, Book, Dysphagia, Esophageal achalasia, Esophageal motility disorder, Physician, American Journal, Medical device, Pharmaceutical industry, Gastroenterology

Dr. Lacy has authored over 225 peer reviewed articles

Key Points: 
  • Dr. Lacy has authored over 225 peer reviewed articles
    IRVINE, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) appointed prominent physician and key opinion leader Brian E. Lacy, M.D., Ph.D., a board-certified gastroenterologist at Mayo Clinic, to its Scientific Advisory Board which is advising the Company on the commercialization of products based on the Biomerica InFoods® Technology platform, beginning with the InFoods® IBS product.
  • I am honored to provide my expertise to Biomerica along with other esteemed members of the Scientific Advisory Board.”
    Dr. Lacy's areas of expertise include irritable bowel syndrome, gastroesophageal reflux disease, dysphagia, achalasia, dyspepsia, gastroparesis, constipation, intestinal pseudo-obstruction and visceral pain.
  • Additionally, Dr. Lacy was the former co-Editor in Chief of the American Journal of Gastroenterology.
  • “Dr.

Top Gastroenterology and Liver Disease Specialist, Dr. David P. Yamini, is Named a 2023 Top Doctor by Los Angeles Magazine

Retrieved on: 
Wednesday, January 11, 2023
Linda, American Gastroenterological Association, Esophagus, Stomach, Disorder, Pancreas, American College, Indigestion, Irritable bowel syndrome, Institute of Liver and Biliary Sciences, PRS, American College of Gastroenterology, ERCP, American Society for Gastrointestinal Endoscopy, Loma Linda University Medical Center, Inflammatory bowel disease, Gastroenterology, Degenerative disease, Cedars-Sinai Medical Center, Patient, Santa Monica Boulevard, Physician, Gastrointestinal Endoscopy, Internal medicine, University, IBS, Gallbladder, Ulcerative colitis, Human, Liver disease, SIBO, Crohn's disease, Liver, Medicine, Los Angeles (magazine)

SANTA MONICA, Calif., Jan. 11, 2023 /PRNewswire-PRWeb/ -- Dr. David Yamini has been placed on Los Angeles Magazine's "Top Doctor" list for 2023. His elite training, credentials and excellent bedside manner as a sought-after gastroenterologist and digestive disease specialist have once again earned him a spot on this coveted list. The magazine's decision for inclusion is made through an extensive nomination and review process conducted by PRS (Professional Research Services), which involves a peer-to-peer survey and voting from practicing physicians throughout Los Angeles County. The list of prominent physicians will appear in the upcoming issue of Los Angeles Magazine and is online at http://www.lamag.com/top-doctors.

Key Points: 
  • SANTA MONICA, Calif., Jan. 11, 2023 /PRNewswire-PRWeb/ -- Dr. David Yamini has been placed on Los Angeles Magazine's "Top Doctor" list for 2023.
  • His elite training, credentials and excellent bedside manner as a sought-after gastroenterologist and digestive disease specialist have once again earned him a spot on this coveted list.
  • The list of prominent physicians will appear in the upcoming issue of Los Angeles Magazine and is online at http://www.lamag.com/top-doctors .
  • At his practice, Dr. David Yamini offers advanced diagnostic and therapeutic procedures and has established a reputation as one of the foremost Los Angeles gastroenterologist and liver disease specialist .

Clayfin and Bandhan Bank win Best Digital Channel/Platform award from IBS Intelligence

Retrieved on: 
Wednesday, January 11, 2023
SME, Digital, Research, Growth, Intelligence, IBS, User experience, Bank, Corporation, Online shopping, Bandhan Bank

CHENNAI, India, Jan. 11, 2023 /PRNewswire/ -- Clayfin Technologies, a leading provider of Digital Customer Experience solutions for Banks and Financial institutions, and Bandhan Bank, one of India's fastest growing banks, have been awarded 'Best Digital Channel/Platform Implementation: Best Project Implementation' at IBSi Global FinTech Innovation Awards 2022. The recognition was basis the implementation of Corporate Internet Banking (version 5.x) by Clayfin as part of Bandhan Bank's vision to enhance their digital services to the SME sector. With the implementation of this new system, the bank now offers enhanced digital banking experience through enhanced self-administration, easy onboarding, more advanced risk mitigation and audit features.

Key Points: 
  • CHENNAI, India, Jan. 11, 2023 /PRNewswire/ -- Clayfin Technologies , a leading provider of Digital Customer Experience solutions for Banks and Financial institutions, and Bandhan Bank , one of India's fastest growing banks, have been awarded 'Best Digital Channel/Platform Implementation: Best Project Implementation' at IBSi Global FinTech Innovation Awards 2022 .
  • The recognition was basis the implementation of Corporate Internet Banking (version 5.x) by Clayfin as part of Bandhan Bank's vision to enhance their digital services to the SME sector.
  • Congratulating Bandhan Bank and Clayfin, Nikhil Gokhale, Head of Research at IBS Intelligence, said, "With Clayfin's corporate internet banking platform, Bandhan Bank was able to offer a unique user experience to its corporate clients.
  • Thanking IBS Intelligence and Bandhan Bank, Rajesh BLN, CEO of Clayfin, added, "Clayfin's new Corporate Internet Platform came in as a right fit for Bandhan Bank on their accelerated path of growth for their corporate banking business.

Vivante Health Adds Cognitive Behavioral Therapy Digital Therapeutic to GIThrive Digestive Health Platform

Retrieved on: 
Tuesday, January 10, 2023
Cognitive behavioral therapy, CBT, Randomized controlled trial, Gastroenterology, Irritable bowel syndrome, Vivante Corporation, ER, Health, Degenerative disease, Patient, IBS, Therapy, Quality of life, Pharmaceutical industry, Medical device

CHICAGO, Jan. 10, 2023 /PRNewswire/ -- Vivante Health, the leading provider of digital digestive health solutions, today announced the expansion of its GIThrive platform for employers and health plans with the addition of a cognitive behavioral therapy (CBT) digital therapeutic designed to help users manage conditions such as irritable bowel syndrome (IBS). The new feature, called IThrive™, is the first CBT solution to be integrated into a comprehensive digestive health platform that has been proven to reduce healthcare spend and improve participants' quality of life.  

Key Points: 
  • CHICAGO, Jan. 10, 2023 /PRNewswire/ -- Vivante Health , the leading provider of digital digestive health solutions, today announced the expansion of its GIThrive platform for employers and health plans with the addition of a cognitive behavioral therapy (CBT) digital therapeutic designed to help users manage conditions such as irritable bowel syndrome (IBS).
  • IThrive is the first of a series of digital therapeutics that Vivante plans to add to the GIThrive platform in order to provide increasingly personalized solutions for individuals suffering from digestive disease.
  • "Evidence-based digital therapeutics have been shown to help alleviate symptoms associated with chronic digestive conditions like irritable bowel syndrome," said Bill Snyder, Vivante Health CEO.
  • IThrive adds to the core capabilities of the GIThrive platform, which provides evidence-based clinical pathways to support individuals who suffer from chronic digestive conditions and their related symptoms.

INDEVCO North America Acquires Perma R Products

Retrieved on: 
Friday, January 6, 2023
Carbon footprint, Booth, GPS, Perma, Plant, Acquisition, INDEVCO Group, Philosophy, IBS, EPS, International, Retail

Richmond, VA, Jan. 06, 2023 (GLOBE NEWSWIRE) -- INDEVCO North America , member of the multinational INDEVCO Group , is pleased to announce the acquisition of Perma R Products, Inc .

Key Points: 
  • Richmond, VA, Jan. 06, 2023 (GLOBE NEWSWIRE) -- INDEVCO North America , member of the multinational INDEVCO Group , is pleased to announce the acquisition of Perma R Products, Inc .
  • The building envelope materials manufacturer, with plants in Mississippi, Georgia, and Tennessee, will be integrated into INDEVCO Building Products.
  • “The acquisition of Perma R,” says Bahjat Frem , Executive Chairman of INDEVCO North America, “is another steppingstone in our commitment to grow into a leading industrial company in the US.
  • “The Perma R – INDEVCO synergies are remarkable and joining as strategic partners will make it easy for customers to do business with us.

GAF Energy's Timberline Solar™ Becomes World's Most Awarded Solar Shingle

Retrieved on: 
Tuesday, January 3, 2023
Good Housekeeping, GAF, National Association, Learning, National Association of Home Builders, Timberline, National Roofing Contractors Association, Invention, TIME, IBS, Standard Industries, Shingles, Certification, The Ib Award, NAHB, Green Builder Media, CES, Multimedia, Fast, Chicago Innovation Awards, Solar energy, UL, Renewable energy

SAN JOSE, Calif., Jan. 3, 2023 /PRNewswire/ -- GAF Energy's Timberline Solar™, the world's first nailable solar shingle, has received more than 30 honors and awards since its introduction one year ago to become the world's most awarded solar shingle. The two most recent awards and honors,TIME's Best Inventions of 2022 and Popular Science's Best of What's New 2022, capped a successful introductory year for Timberline Solar™. GAF Energy, a Standard Industries company and the leading provider of solar roofing in North America, introduced Timberline Solar™ in January 2022. The innovative solar roof was developed and is produced at the company's R&D and manufacturing facility in San Jose, California.

Key Points: 
  • World's First Nailable Solar Shingle Ends Year with 30+ Awards and Honors: TIME, Popular Science Honors Cap Successful Introductory Year
    SAN JOSE, Calif., Jan. 3, 2023 /PRNewswire/ -- GAF Energy's Timberline Solar™ , the world's first nailable solar shingle, has received more than 30 honors and awards since its introduction one year ago to become the world's most awarded solar shingle.
  • GAF Energy , a Standard Industries company and the leading provider of solar roofing in North America, introduced Timberline Solar™ in January 2022.
  • Consumers interested in learning more about Timberline Solar™ can visit: https://www.gaf.energy/timberline-solar/
    GAF Energy is transforming the solar and roofing industries to generate energy from every roof.
  • The company's leading product, the Timberline Solar™ roof system, incorporates the world's first nailable solar shingle to create an attractive, durable, and reliable solar roof.

Managing a Food Intolerance During the Holidays? Use Intoleran

Retrieved on: 
Thursday, December 22, 2022
Holiday, Diet, Fructan, Lactose, Starch, Food, Carbohydrate, Fructose, Enzyme, IBS, FODMAPS, Human, Edible, Sucrose, Eating, Galactose, Food intolerance, Bloating, Dairy product

Those who manage food intolerances often adopt certain diets and shop in a way that limits or avoids troublesome foods.

Key Points: 
  • Those who manage food intolerances often adopt certain diets and shop in a way that limits or avoids troublesome foods.
  • This is useful for the majority of the year, but it can be challenging living with an intolerance during the holiday season.
  • For those managing a food intolerance this holiday season, Intoleran can help.
  • Intoleran products assist the digestive system by helping to properly digest food and, consequently, avoid many of the unpleasant side effects that come from food intolerances.

GAF Energy Launches Timberline Solar™ Roof in Metro Atlanta

Retrieved on: 
Tuesday, December 20, 2022
Good Housekeeping, GAF, National Association, National Association of Home Builders, Timberline, TIME, Senior, IBS, Standard Industries, Shingles, Certification, The Ib Award, NAHB, CES, Multimedia, Fast, Chicago Innovation Awards, Popular Science, Solar energy, UL, Renewable energy, Atlanta metropolitan area

ATLANTA, Dec. 20, 2022 /PRNewswire/ -- GAF Energy, a Standard Industries company and the leading provider of solar roofing in North America, today announced the launch of its innovative Timberline Solar™ roof in the Atlanta area. Timberline Solar™, the only system to directly integrate solar technology into traditional roofing processes and materials, is now available to Atlanta-area residents for installation by local roofers. The solar roofing system incorporates the world's first nailable solar shingle, the Timberline Solar™ Energy Shingle (ES),  which is assembled domestically at GAF Energy's U.S. manufacturing and R&D facility.

Key Points: 
  • ATLANTA, Dec. 20, 2022 /PRNewswire/ -- GAF Energy , a Standard Industries company and the leading provider of solar roofing in North America, today announced the launch of its innovative Timberline Solar™ roof in the Atlanta area.
  • The solar roofing system incorporates the world's first nailable solar shingle, the Timberline Solar™ Energy Shingle (ES),  which is assembled domestically at GAF Energy's U.S. manufacturing and R&D facility.
  • Metro Atlanta homeowners interested in solar roofing options and roofers interested in installing GAF Energy products can find out more at: www.gaf.energy .
  • GAF Energy is transforming the solar and roofing industries to generate energy from every roof.

SCIB Concludes 46th AGM Successfully

Retrieved on: 
Thursday, December 8, 2022
Electricity, SCIB, Health, Water, Dato, IBS, MRT3, Engineering, AGM, Companies Act 2006, Trust, EPCC, Remuneration, Industrialised building system (IBS), Economic development, Management

KUCHING, MALAYSIA, Dec 8, 2022 - (ACN Newswire) - Civil engineering specialist Sarawak Consolidated Industries Berhad (SCIB) held the Company's 46th AGM virtually today in which shareholders voted to reappoint NEXIA SSY PLT as the auditor and authorised the directors to fix its remuneration.

Key Points: 
  • KUCHING, MALAYSIA, Dec 8, 2022 - (ACN Newswire) - Civil engineering specialist Sarawak Consolidated Industries Berhad (SCIB) held the Company's 46th AGM virtually today in which shareholders voted to reappoint NEXIA SSY PLT as the auditor and authorised the directors to fix its remuneration.
  • Group Managing Director of SCIB, Encik Rosland bin Othman, said, "We are happy to engage with our shareholders virtually in the AGM today and answer their questions.
  • Mohd Abdul Karim and Datu Haji Abdul Hadi for their years of leadership and dedication to SCIB."
  • As of 30 November 2022, SCIB has an order book of RM564.7 million with earnings visibility until 2026.

Intrinsic Medicine and Phoenix Biotech Acquisition Corp. Mutually Agree to Terminate Business Combination Agreement

Retrieved on: 
Wednesday, December 7, 2022
Acquisition, Health maintenance organization, Annual report, FDA, IBS, Probability, Biotechnology, Prospectus, Irritable bowel syndrome, Constipation, Intrinsic and extrinsic properties, Inflammation, GBA, Compte rendu, Veteran, Patient, Therapy, Pharmaceutical industry, Risk management

“Intrinsic was encouraged by the positive feedback from prospective investors regarding the attractiveness of our novel and capital-efficient approach to developing transformative new therapeutics.

Key Points: 
  • “Intrinsic was encouraged by the positive feedback from prospective investors regarding the attractiveness of our novel and capital-efficient approach to developing transformative new therapeutics.
  • “After careful thought and consideration, we mutually determined that this action is in the best interest of all parties given current market conditions.
  • Additional information regarding the termination of the business combination agreement is provided in a Current Report on Form 8-K filed by PBAX with the U.S. Securities and Exchange Commission and is available at www.sec.gov.
  • About Phoenix Biotech Acquisition Corp.
    Phoenix Biotech Acquisition Corp. (NASDAQ: PBAX) is a blank-check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.